AMPH (AMPH) Stock Price & Analysis
AMPH (AMPH) fell 2.77% to USD 23.18 as of September 8, 2026 at 06:22 UTC, according to Nexqual real-time market data.
AMPH last closed at USD 23.18; the session ranged USD 23.07–23.74 on volume of 650,129 shares. Market capitalization is —, with a 52-week range of USD 16.65–29.52 (NMS). Source: Nexqual, September 8, 2026 at 06:22 UTC.
Key Statistics (as of September 8, 2026 at 06:22 UTC)
| Price | USD 23.18 |
|---|---|
| Change | ▼ 2.77% (down) |
| Previous Close | USD 23.18 |
| Open | USD 23.18 |
| Day Range | USD 23.07 – 23.74 |
| 52-Week Range | USD 16.65 – 29.52 |
| Volume | 650,129 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (AMPH)
Nexqual's technical model rates AMPH "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 06:22 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 67.02 (neutral) |
| vs SMA50 | Above (USD 20.56) |
| MACD | 0.84 (positive) |
From AMPH's Latest SEC 10-K Filing (filed 2026-02-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| COLL | Collegium Pharmaceutical, Inc. | USD 23.53 | ▼ 3.17% |
| ANIP | ANI Pharmaceuticals, Inc. | USD 71.23 | ▼ 2.5% |
| PCRX | Pacira BioSciences, Inc. | USD 26.35 | ▼ 0.87% |
| SUPN | Supernus Pharmaceuticals, Inc. | USD 43.53 | ▼ 1.14% |
| ANGO | AngioDynamics, Inc. | USD 15.2 | ▼ 2.69% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:22 UTC. This page is informational and not investment advice.